Journeys of adjustment: the experiences of adolescents living with juvenile idiopathic arthritis.Cartwright T, Fraser E, Edmunds S, Wilkinson N, Jacobs K. Child Care Health Dev. 2014
Mucocutaneous manifestations in a UK national cohort of juvenile-onset systemic lupusery thematosus patients. Chiewchengchol D, Murphy R, Morgan T, Edwards SW, Leone V,Friswell M, Pilkington C, Tullus K, Rangaraj S, McDonagh JE, Gardner-Medwin J, WilkinsonN, et al; UK JSLE Study Group. Rheumatology (Oxford). 2014 53 (8):1504-12
Efficacy of tocilizumab for interstitial lung disease in an undifferentiated autoinflammatory disorder partially responsive to anakinra. Keidel SM, Hoyles RK, Wilkinson NM.Rheumatology (Oxford). 2014;53 (3):573-4.
Isolated paediatric neurosarcoidosis presenting as epilepsia partialis continua: a case reportand review of literature. Anand G, Sin FE, Soilleux E, Chandra J, Piddington K, QuaghebeurG, Wilkinson N, Zaiwalla Z, Kennett R, McShane T. Eur J Paediatr Neurol. 2013;17(5):429-36
Disease activity assessment in childhood vasculitis: development and preliminary validation ofthe Paediatric Vasculitis Activity Score (PVAS). Dolezalova P, Price-Kuehne FE, Özen S,Benseler SM, Cabral DA, Anton J, Brunner J, Cimaz R, O'Neil KM, Wallace CA, Wilkinson N,et al. Ann Rheum Dis. 2013;72 (10):1628-33
Disease activity, severity, and damage in the UK Juvenile-Onset Systemic LupusErythematosus Cohort. Watson L, Leone V, Pilkington C, Tullus K, Rangaraj S, McDonaghJE, Gardner-Medwin J, Wilkinson N, et al; UK Juvenile-Onset Systemic Lupus Erythematosus Study Group. Arthritis Rheum. 2012;64(7):2356-65
Wilkinson N, Page J, Uribe A, Espinosa V, Cabral D. Establishment of a Pilot PaediatricRegistry for Chronic Vasculitis is Both Essential and Feasible: A Childhood Arthritis and Rheumatology Alliance (CARRA) Survey J Rheumatology 2007
Ruperto N, Lovell DJ, Cuttica R, Wilkinson N, et al. A randomized, placebo-controlled trial ofinfliximab plus methotrexate for the treatment of polyarticular-course juvenile rheumatoidarthritis. Arthritis Rheum. 2007 Sep;56(9):3096-106
Woo P. Wilkinson N. Prieur AM. Southwood T. Leone V. Livermore P. Wythe H. Thomson D.Kishimoto T. Open label phase II trial of single, ascending doses of MRA in Caucasian children with severe systemic juvenile idiopathic arthritis: proof of principle of the efficacy ofI L-6 receptor blockade in this type of arthritis and demonstration of prolonged clinical improvement. Arthritis Research & Therapy 2005;7, R1281-8.
Wilkinson N, Erizonova E, Zeft A, Cabral D. Infliximab as rescue therapy in three children withWegener’s Granulomatosis. Rheumatology 45: 1047-1048.
Wilkinson N, Jackson G, Gardner-Medwin.J Biologic therapies for juvenile arthritis. Archivesof Disease in Childhood, 2003;88:186-91.
AR Bedford Russell, A Emerson, NMR Wilkinson et al. A trial of recombinant human granulocyte colony stimulating factor for the treatment of very low birth weight infants with presumed sepsis and neutropenia. Archives of Diseases in Childhood, Fetal & Neonatal Edition 2001;84:F1-5
Books and reviews
J Bakshi and N Wilkinson. Periodic Fevers and Autoinflammatory Conditions. Paediatrics and Child Health 2014
N Wilkinson and C Nnadi. Back Pain in Children and Adolescents Paediatrics and Child Health 2013
M Rogers, A Wainwright, N Wilkinson Acute Painful Joints Paediatrics and Child Health Volume 20, Issue 2, February 2010
NMR Wilkinson and HE Venning. Juvenile Idiopathic Arthritis: Management. Current Paediatrics 1999;9:102-107
Contributing author Paediatric Rheumatology, Edited by H Foster and P Brogan 2012
Contributing author to Illustrated paediatrics for membership exams, edited by Dr.s Rachel Sidwell and Michael Thompson 2009 and 2013
Contributing author for Handbook of Rheumatology, edited by Margaret Callan 2010
Contributing author to Luqmani R, Robb J, Porter D, Keating J (editors) Textbook of Orthopaedics, Trauma and Rheumatology (Elsevier Health Sciences) 2008 and 2012
Contributor to NHS Clinical Knowledge Summaries topic on Osgood schlatter's 2009 and Anterior Knee Pain 2010